Support: 888-992-3836
Copyright © 2023 InvestorsHub Inc.
Replies to post #222330 on Biotech Values
dewophile
11/16/18 11:12 AM
#222335 RE: DewDiligence #222330
DewDiligence
12/07/18 8:15 AM
#222693 RE: DewDiligence #222330
[Neither] Imfinzi monotherapy [nor] the combination of Imfinzi plus tremelimumab…[met]…the primary endpoints of improving OS compared to SoC chemotherapy…